About 5 results found for searched term "JM6" (0.051 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M8381 | JM6 | Others |
| JM6 is a precursor compound inhibitor of Kynurenine 3-monooxygenase (KMO) that increases kynurenine acid levels and reduces extracellular glutamate in the brain. | ||
| M24706 | Elgemtumab | EGFR/HER2 |
| LJM716 | ||
| Elgemtumab(LJM716) is a fully human IgG monoclonal antibody. Elgemtumab can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor potential. | ||
| M28129 | Satraplatin | DNA Alkylator/Crosslinker |
| BMS182751; BMY45594; JM216 | ||
| Satraplatin is an alkylating agent, with potent antitumor effect. | ||
| M41682 | JMJD6-IN-1 | Histone demethylase |
| JMJD6-IN-1 is a JMJD6 inhibitor, with an inhibition rate of 82% at 10 μM. | ||
| M45356 | HJM-561 | PROTAC |
| HJM-561 is a potent, selective, orally bioavailable EGFR PROTAC.HJM-561 preserves the activity of cells expressing wild EGFR, and a mouse model shows inhibition of 19del//T790M/C797S, overcoming Osimertinib resistance. Possesses anti-tumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
